Marc Better, VP, Product Sciences at Kite Pharma, Inc. (KITE), sold 9,000 shares at $75.48 ($687K) on 2015-12-01, disclosed to the SEC on 2015-12-03.
Scheduled sale ($687k) by VP, Product Sciences under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.53 | 905 | $67K | 9.8% |
| 2 | $75.48 | 2,772 | $209K | 30.5% |
| 3 | $76.57 | 3,664 | $281K | 40.8% |
| 4 | $77.50 | 1,215 | $94K | 13.7% |
| 5 | $78.53 | 254 | $20K | 2.9% |
| 6 | $80.59 | 100 |
| $8K |
| 1.2% |
| 7 | $82.42 | 90 | $7K | 1.1% |
| Total | $76.31 avg | 9,000 | $687K | 100% |
| Filing → |
| KITE | SELL | 2015-11-04 | $640K | — | Filing → |
| KITE | SELL | 2015-10-02 | $493K | — | Filing → |
| KITE | SELL | 2015-09-03 | $466K | — | Filing → |